Filing Details

Accession Number:
0001127602-17-021004
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-08 20:21:42
Reporting Period:
2017-06-07
Filing Date:
2017-06-08
Accepted Time:
2017-06-08 20:21:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711404 Cooper Companies Inc COO Ophthalmic Goods (3851) 942657368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1181958 R Carol Kaufman 6140 Stoneridge Mall Drive
Suite 590
Pleasanton CA 94588
Evp, Sec. & Chief Gov. Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-07 16,500 $13.21 60,419 No 4 M Direct
Common Stock Acquisiton 2017-06-07 8,500 $13.10 68,919 No 4 M Direct
Common Stock Disposition 2017-06-07 1,500 $242.67 67,419 No 4 S Direct
Common Stock Disposition 2017-06-07 23,500 $243.26 43,919 No 4 S Direct
Common Stock Acquisiton 2017-06-08 19,092 $13.10 63,011 No 4 M Direct
Common Stock Disposition 2017-06-08 19,092 $242.26 43,919 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2017-06-07 16,500 $0.00 16,500 $13.21
Common Stock Stock Options (Right to Buy) Disposition 2017-06-07 8,500 $0.00 8,500 $13.10
Common Stock Stock Options (Right to Buy) Disposition 2017-06-08 19,092 $0.00 19,092 $13.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-12-09 No 4 M Direct
24,500 2018-12-10 No 4 M Direct
5,408 2018-12-10 No 4 M Direct
Footnotes
  1. Sale price represents an average of sale prices ranging from $242.5850 to $242.8100.
  2. Sale price represents an average of sale prices ranging from $242.9200 to $243.8500.
  3. Sale price represents an average of sale prices ranging from $242.0000 to $242.6300.
  4. All shares granted under this option are currently exercisable.